Experience and Innovation
for targeted protein quantification
Promise Proteomics was created in 2010 and is now a full subsidiary of the Aguettant Group, which provides a high level of expertise, products and solutions in quantitative proteomics.
Promise Proteomics is dedicated to both the measurement of mAbs concentrations in biological fluids using mass spectrometry as well as the custom production of labelled proteins or mAbs of choice.
Promise Proteomics helps customers all around the world to achieve reliable and accurate results when using mass spectrometry.
The company is managed by:
Eric Rougemond (MD)
Chief Executive Officer
Dorothée Lebert
Chief Scientific Officer
Our success in numbers
Our commitments
High-quality products developed for and approved by our clients worldwide
High-level expertise based on strong R&D
Custom solutions tailored to client requirement
Cutting-edge technologies including state of the art LC-MS instrumentation
